Wustl CIViC Track Settings
 
Wustl CIViC: Clinical Interpretation of Variants in Cancer

Display mode:   

Show only items with score at or above:   (range: 0 to 1000)


Display data as a density graph:

Data schema/format description and download
Assembly: Human Feb. 2009 (GRCh37/hg19)
Data last updated at UCSC: 2016-12-07 13:55:07

Description

CIViC is an open access, open source, community-driven web resource for Clinical Interpretation of Variants in Cancer.

Variants are mapped to the genomic location, unless no RefSeq transcript matches the reference amino acid of the variant. Gene-level data is mapped to the location of the RefSeq transcript of the gene.

Display conventions

Each combination of (gene, variant, disease) tuple in the database is represented by an individual feature. Mouseovers show the drugs. Clicking on the feature shows all details associated to the entry in CIViC.

This is very "sparse" track, with only 195 features and a total genome coverage of 3Mbp. The ten most annotated genes in this track are the typical cancer genes (number of database entries in parentheses): NPM1 (39), BRAF (30), DNMT3A (29), KRAS (28), FLT3 (28), KIT (22), PIK3CA (19), WT1 (16), NRAS (14), EGFR (13).

The last field "Mapped to genome via" was added by the mapping pipeline and is not part of the database. It shows, using HGVS, how the variant was mapped to the genome. The mapping first checks the amino acid on all RefSeq Protein sequences at the indicated position, maps this to the corresponding RefSeq cDNA sequence and then uses pslMap to find the correct hg19 position.

Fusion genes are mapped to the gene locations of both genes of the fusion.

Data access

The full database can be downloaded from CIViC. The nightly dump from Mar 1 2016 was used for this track. The mapped locations on hg19 are available as a bigBed file.

Credits

Thanks to Obi and Malachi Griffith for support with the data import.

References

"Clinical cancer sequencing and integrated analysis of whole genomes, exomes and transcriptomes" AACR Special Conference: Translation of the Cancer Genome, February 7-9, 2015